期刊文献+

唑来膦酸对骨质疏松性大鼠骨缺损修复的实验研究 被引量:8

Effect of zoledronic acid on repair of osteoporosis rats bone defect
原文传递
导出
摘要 目的探索唑来膦酸对骨质疏松性大鼠股骨干骺端骨缺损修复的影响。方法 30只3个月龄SPF级雌性SD大鼠,随机分为2组:1实验组,唑来膦酸注射组;2空白对照组,生理盐水注射组。将2组先去卵巢建立OVX(卵巢切除)模型,2组大鼠OVX模型饲养满3个月后,骨质疏松模型成功建立,随后再建立大鼠双侧股骨干骺端2.5 mm贯通性骨缺损模型。实验组于缺损手术后行尾静脉注射唑来膦酸1次(0.1 mg/kg),空白对照组给予等剂量的生理盐水尾静脉注射。分别于缺损术后6、12周进行X线观察,骨密度检测,HE骨组织切片观察,TRAP破骨细胞活性等检测。结果缺损术后6、12周,实验组和空白对照组对比发现:实验组的大鼠模型体重增加减慢,股骨骨密度增加变快;缺损区X线扫描较空白对照组有明显的新生骨生成,HE骨组织切片可见缺损区有分布密集的骨小梁和较多核深染的骨细胞。TRAP染色显示:实验组的破骨细胞活性降低,数量减少。结论唑来膦酸可较好地促进骨质疏松性大鼠股骨干骺端骨缺损的修复。 Objective To investigate the effect of zoledronic acid on the repair of defect of femoral epiphyseal end of osteoporosis rats. Methods Thirty 3-month-old SPF SD female rats were randomly divided into two groups: (1)the experimental group, zoledronic acid group; (2)the blank control group, saline group. AH rats were ovarieetomized and raised 3 months for osteoporosis model, and a 2.5 mm defect on the both femoral epiphyseal end was created. The experimental group was injected zoledronic acid (0.1 mg/kg) through tail vein, and blank control group was given the same amount of saline the same way. The X-ray observation, histopathological observation, and the TRAP osteoclast activity detection were completed respectively at 6 and 12 weeks after surgery. Results Six and 12 weeks after the operation, the experimental groups had a slower weight gain, and BMD increased faster; X-ray scan on the defect area showed that more bone tissue was generated compared with blank control group. In the experimental groups, a large number of trabeeular bone and'more hyperehromatism-nuelear bone cells were observed in the pathological section of the defect area. TRAP showed that the activity of osteoclast was restrained and the number of the osteoclast declined in experimental groups. Conclusion The zoledronie acid can promote the repair of the defect in femoral epiphyseal end of osteoporosis rats.
出处 《中国骨与关节损伤杂志》 2015年第7期736-739,共4页 Chinese Journal of Bone and Joint Injury
基金 温州市2011年第二期科技计划项目(Y20110168)
关键词 唑来膦酸 骨质疏松 骨缺损 新生骨 Zoledronic acid Osteoporosis Bone defect New bone
  • 相关文献

参考文献6

二级参考文献64

  • 1戚孟春,胡静,邹淑娟,韩力赤,罗恩.大鼠骨髓间充质干细胞和颅骨成骨细胞在张应力下细胞骨架的改变[J].华西口腔医学杂志,2005,23(2):110-112. 被引量:24
  • 2唐坚,孙月华.β-磷酸三钙与异体骨植骨治疗跟骨关节内骨折的比较研究[J].中国骨与关节损伤杂志,2006,21(6):447-449. 被引量:13
  • 3Miller R J, Tsatalos OG., Williams. DataWeb: customizable database publishing for the web[J]. J.H. IEEE Multimedia , 1997,4(4) : 14-21.
  • 4Jorg Zedler, Marwan Ramadan. I-Media- an integrated media server and media database as a basic component of a cross media publishing system[J]. Computer & Graphics. 1997, 21(6): 693-702.
  • 5Maria Langer. Database publishing with FileMaker pro on the Web[M]. California: Peachpit Press, 1998,4.
  • 6Erich Gamma, Richard Helm, Ralph Johnson, John Vlissides. Design patterns: elements of reusable object-oriented software[M]. Massachusetts :Addison Wesley,1995.
  • 7Cornwall R ,Gilbert MS,Koval KJ,et al. Functional outcomes and mortality vary among different types of hip fractures: a function of patient characteristics[J]. Clin Orthop Relat Res,2004,425: 64-71.
  • 8Kanis JA,Oden A,Johnell O,ct al. The components of excess mor- tality after hip fracture[J]. Bone,2003,32(5):468-473.
  • 9Sharma H, Vashishtha P, Sharma R, et al. Gender differences in pa- tients with hip fracture: a greater risk of morbidity and mortality in men[J]. Orthop Trauma,2005,19: 365-366.
  • 10Nakamura K,Takahashi S,Oyama M ,et al. Prior non-;hip limb frac- ture predicts subsequent hip fracture in institutionalized elderly peo- ple[J]. Osteoporos Int,2010,21(8):1411-1416.

共引文献41

同被引文献78

  • 1黄颖,马武开,王莹,陆道敏,陈昌明,唐芳,姚血明.苗药金乌健骨胶囊对糖皮质性骨质疏松模型大鼠Hedgehog信号的影响[J].中药材,2021,44(11):2673-2676. 被引量:6
  • 2原小兵,马玉伟.唑来膦酸对骨质疏松症患者骨代谢和骨转换指标的影响[J].中国合理用药探索,2019,16(3):82-84. 被引量:5
  • 3谢新荣,罗佐杰,秦映芬,梁杏欢,张英.利塞膦酸钠对绝经后骨质疏松症的疗效与安全性研究[J].中国现代医学杂志,2007,17(14):1729-1732. 被引量:6
  • 4Liu Z,Weaver J,De Papp A,et al.Disparities in osteoporosis treat- ments[J].Osteoporos Int,2016,27(2):509-519.
  • 5Marques AfFerreira RJ,Santos E,et al.The accuracy of osteoporotic fracture risk prediction tools:a systematic review and meta-analysis [J].Ann Rheum Dis,2015,74(11):1958-1967.
  • 6Nguyen TV,Seeman E.Osteoporosis:treat and live,or let die twice more likely[J].J Bone Miner Res,2015,30(9):1551-1552.
  • 7Morabito N,Catalano A,Gaudio A,et al.Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major -related osteoporosis[J].J Bone Miner Metab,2015,PMID:26204844.
  • 8Leslie WD,Brennan -Olsen SL,Morin SN,et al.Fracture prediction from repeat BMD measurements in clinical practice[J],Osteoporos Int,2016,27(1):203-210.
  • 9Schmidt J,Dahlgren E,Brannstrom M,et al.Body composition,bone mineral density and fractures in late postmenopausal women with polycystic ovary syndrome-a long-term follow-up study[J].Clin En- docrinol(Oxf),2012,77(2):207-214.
  • 10Albertazzi P,Bottazzi M,Steel SA.Bone mineral density and depot medroxyprogesterone acetate[J].Contraception,2006,73(6):577-583.

引证文献8

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部